The U.S. Food and Drug Administration approved Dalvance (dalbavancin), a new antibacterial drug for treatment of skin infections in adults.
Read the full article on Becker's Hospital Review.
Read the full article on Becker's Hospital Review.
Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.
Becker's Websites
Virtual Learning
Conferences
Contact Us